Nonsteroidal Antiinflammatory Drugs
J ournal of Medicinal Chemistry, 1997, Vol. 40, No. 6 989
(b) Engelhardt, G.; Bo¨gel, R.; Schnitzer, C.; Utzmann, R.
Meloxicam: Influence on Arachidonic Acid Metabolism. Part I.
In Vitro Findings. Biochem. Pharmacol. 1996, 51, 21-28. (c)
Engelhardt, G.; Bo¨gel, R.; Schnitzer, C.; Utzmann, R. Meloxi-
cam: Influence on Arachidonic Acid Metabolism. Part II. In Vivo
Findings. Biochem. Pharmacol. 1996, 51, 29-38.
Refer en ces
(1) Vane, J . R. Inhibition of Prostaglandin Synthesis as a Mecha-
nism of Action for Aspirin-Like Drugs. Nature 1971, 231, 232-
237.
(2) (a) O’Banion, M. K.; Sadowski, H. B.; Winn, V.; Young, D. A. A
Serum- and Glucocorticoid-Regulated 4-Kilobase mRNA Encodes
a Cyclooxygenase Related Protein. J . Biol. Chem. 1991, 266,
23261-23267. (b) O’Banion, M. K.; Winn, V.; Young, D. A. cDNA
Cloning and Functional Activity of a Glucocorticoid-Regulated
Inflammatory Cyclooxygenase. Proc. Natl. Acad. Sci. U.S.A.
1992, 89, 4888-4892. (c) Kujubu, D. A.; Herschmann, H. R.
Dexamethasone Inhibits Mitogen Induction of the TIS10 Pros-
taglandin Synthase/Cyclooxygenase Gene. J . Biol. Chem. 1992,
267, 7991-7994.
(3) (a) Vane, J . R. Towards a Better Aspirin. Nature 1994, 367, 215-
216. (b) Vane, J . R.; Botting, R. M. New Insights into the Mode
of Action of Anti-Inflammatory Drugs. Inflamm Res. 1995, 44,
1-10. (c) DeWitt, D. L.; Meade, E. A.; Smith, W. L. PGH
Synthase Isoenzyme Selectivity: The Potential for Safer Non-
steroidal Antiinflammatory Drugs. Am. J . Med. 1993, 95 (Suppl.
2A), 2A-40S-2A-44S.
(12) Lombardino, J . G.; Wiseman, E. H.; McLamore, W. M. Synthesis
and Antiinflammatory Activity of Some 3-Carboxamides of
2-Alkyl-4-hydroxy-2H-1,2-benzothiazine 1,1-Dioxides. J . Med.
Chem. 1971, 14, 1171-1175.
(13) Lombardino, J . G. Preparation of Substituted 1,2-Benzoisothia-
zolin-3-one 1,1-Dioxides (o-Benzoic Sulfimides). J . Org. Chem.
1971, 36, 1843-1845. (b) Lombardino, J . G.; Wiseman, E. H.;
Chiaini, J . Potent Antiinflammatory N-Heterocyclic 3-Carboxa-
mides of 4-Hydroxy-2-methyl-2H-1,2-benzothiazine 1,1-Dioxide.
J . Med. Chem. 1973, 16, 493-496.
(14) Lombardino, J . G.; Wiseman, E. H. Piroxicam and Other Anti-
Inflammatory Oxicams. Med. Res. Rev. 1982, 2, 127-152.
(15) Lombardino, J . G.; Wiseman, E. H. 3,4-Dihydro-2-alkyl-3-oxo-
2H-1,2-benzothiazine-4-carboxamide 1,1-Dioxides. J . Med. Chem.
1971, 14, 973-977.
(16) Lombardino, J . G. Benzothiazine Dioxides. U.S. Patent 3,591,-
584, 1971.
(17) Pfister, R.; Zeller, P.; Binder, D.; Hromatka, O. Thiazine Deriva-
tives. Ger. Offen. 2,835,760, 1979.
(18) Lombardino, J. G. Synthesis of 4-Hydroxy-2-methylisocarbostyril-
3-carboxanilides. J . Heterocycl. Chem. 1970, 7, 1057-1060.
(19) Kadin, S. B. On the Transmission of Polar Effects by the Amide
Moiety. J . Org. Chem. 1971, 36, 1160-1161.
(20) Malamas, M. S.; Hohman, T. C.; Millen, J . Novel Spirosuccin-
imide Aldose Reductase Inhibitors Derived from Iso-
quinoline-1,3-diones: 2[(4-Bromo-2-fluorophenyl)methyl]-6-fluo-
rospiro[isoquinoline-4(1H), 3′-pyrrolidine]-1,2′,3,5′(2H)-tetrone
and Congeners. 1. J . Med. Chem. 1994, 37, 2043-2058.
(21) (a) Zinnes, H.; Lindo, N. A. 4-Hydroxy-2H-1-benzothiopyran-3-
carboxamides and their Corresponding S-Oxides. U.S. Patent
3,838,073, 1974. (b) Zinnes, H.; Lindo, N. A. Heterocyclic Amides
of 4-Hydroxy-2H-1-benzothiopyran-3-carboxylic acid 1,1-dioxide.
U.S. Patent 3,828,055, 1974. (c) Zinnes, H.; Lindo, N. A.
Heterocyclic Amides of 4-Hydroxy-2H-1-benzothiopyran-3-car-
boxylic acid 1,1-dioxide. U.S. Patent 3,826,791, 1974.
(22) (a) Krollpfeiffer, F.; Schultze, H.; Uber Thiochromanone und
Umwendlungsprodukte. (Thiochromanones and Transformation
Products.) Ber. 1923, 56B, 1819-1824. (b) Breitschoh, R.;
Seebach, D. Herstellung von Stereoisomeren 3-Sulfinylbutter-
sauren aus (R)- und (S)-4-methyl-2-oxetanon. (Preparation of
Stereoisomers of 3-Sulfinylbutyric Acid From (R)- and (S)-4-
Methyl-2-oxetanone.) Synthesis 1992, 83-89. (c) Tercio, J .;
Ferreira, B.; Catani, V.; Comasseto, J . V. Synthesis of 22-
Dimethyl-2H-thiochromens, the Sulfur Analogs of Precocenes.
Synthesis 1987, 149-153.
(4) (a) Meade, E. A.; Smith, W. L.; DeWitt, D. L. Differential
Inhibition of Prostaglandin Endoperoxide Synthase (Cyclooxy-
genase) Isoenzymes by Aspirin and Other Non-Steroidal Anti-
inflammatory Drugs. J . Biol. Chem. 1993, 268, 6610-6614. (b)
Laneuville, O.; Breuer, D. K.; DeWitt, D. L.; Hla, T.; Funk, C.
D.; Smith, W. L. Differential Inhibition of Human Prostaglandin
Endoperoxide
H Synthases-1 and -2 by Nonsteroidal Anti-
Inflammatory Drugs. J . Pharmacol. Exp. Ther. 1994, 271, 927-
934. (c) Mitchell, J . A.; Akerasereenont, P.; Thiemermann, C.;
Flower, R. J . Selectivity of Nonsteroidal Antiinflammatory Drugs
as Inhibitors of Constitutive and Inducible Cyclooxygenase. Proc.
Natl. Acad. Sci. U.S.A. 1994, 90, 11693-11697. (d) Grossman,
C. J .; Wiseman, J .; Lucas, F. S.; Treuethick, M. A.; Birch, P. J .
Inhibition of Constitutive and Inducible Cyclooxygenase Activity
in Human Platelets and Mononuclear Cells by NSAIDS and
Cox-2 Inhibitors. Inflamm Res. 1995, 44, 253-257.
(5) Futaki, N.; Takahashi, S.; Yokoyama, I.; Arai, I.; Higuchi, S.;
Otomo, S. NS-398, a New Anti-inflammatory Agent, Selectively
Inhibits Prostaglandin G/H Synthase/Cyclooxygenase (COX-2)
Activity In Vitro. Prostaglandins 1994, 47, 55-59.
(6) Gans, K. R.; Galbraith, W.; Roman, R. J .; Haber, S. B.; Kerr, J .
S.; Schmidt, W.K.; Smith, C.; Hewes, W. E.; Ackerman, N. R.
Anti-Inflammatory and Safety Profile of DuP 697, a Novel Orally
Effective Prostaglandin Synthesis Inhibitor. J . Pharmacol. Exp.
Ther. 1990, 254, 180-187.
(7) (a) Swingle, K. F.; Moore, G. G. I.; Grant, T. J . 4-Nitro-2-
Phenoxymethanesulfonamide (R-805): a Chemically Novel Anti-
inflammatory Agent. Arch. Int. Pharmacodyn. 1976, 221, 132-
139. (b) Prasit, P.; Black, W. C.; Chan, C.-C.; Ford-Hutchinson,
A. W.; Gauthier, J . Y.; Gordon, R.; Guay, D.; Kargman, S.; Lau,
C. K.; Li, C.-S.; Mancini, J .; Ouimet, N.; Roy, P.; Tagari, P.;
Vickers, P.; Wong, E.; Young, R. N.; Zamboni, R. L. L-745,337:
A Selective Cyclooxygenase-2 Inhibitor. Med. Chem. Res. 1995,
5, 364-374.
(8) (a) Li, J . J .; Norton, M. B.; Reinhard, E. J .; Anderson, G. D.;
Gregory, S. A.; Isakson, P. C.; Koboldt, C. M.; Masferrer, J . L.;
Perkins, W. E.; Seibert, K.; Zhang, Y.; Zweifel, B. S.; Reitz, D.
B. Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors
and Orally Active Anti-Inflammatory Agents. J . Med. Chem.
1996, 39, 1846-1856. (b) Reitz, D. B.; Li, J . J .; Norton, M. B.;
Reinhard, E. J .; Collins, J . T.; Anderson, G. D.; Gregory, S. A.;
Koboldt, C. M.; Perkins, W. E.; Siebert, K.; Isakson, P. C.
Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclo-
pentenes are Potent and Orally Active COX-2 Inhibitors. J . Med.
Chem. 1994, 37, 3878-3881.
(23) Zinnes, H.; Lindo, N. A.; Sicar, J . C.; Schwartz, M. L.; Shavel,
J ., J r. 1,2-Benzothiazines. 6. 3-Carbamoyl-4-hydroxy-2-H-1,2-
benzothiazine 1,1-Dioxides as Antiinflammatory Agents. J . Med.
Chem. 1973, 16, 44-48.
(24) Sheppard, G. S.; Pireh, D.; Carrera, G. M., J r.; Bures, M. G.;
Heyman, H. R.; Steinman, D. H.; Davidsen, S. K.; Philips, J .
G.; Guinn, D. E.; May, P. D.; Conway, R. G.; Rhein, D. A.;
Calhoun, W. C.; Albert, D. H.; Magoc, T. J .; Carter, G. W.;
Summers, J . B. 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles,
a
Novel series of Platelet Activating Factor Antagonists. J . Med.
Chem. 1994, 37, 2011-2032.
(25) Lecompte, M.; Laneuville, O.; J i, C.; DeWitt, D. L.; Smith, W.
L. Acetylation of Human Prostaglandin Endoperoxide Syn-
thase-2 (cyclooxygenase-2) by Aspirin. J . Biol. Chem. 1994, 269,
13207-13215.
(26) Kurumbail, R. G.; Stallings, W. C.; McDonald, J . J .; Stevens, A.
M.; Stegeman, R. A.; Gierse, J . K.; Miyashiro, J . M.; Penning,
T. D.; Seibert, K.; Isakson, P. C. Crystal Structure of Murine
Cyclooxygenase-2. Prostaglandins, Leukotrienes Essent. Fatty
Acids 1996, 55 (Suppl. 1), A62, 20.
(27) Black, W. C.; Bayly, C.; Belley, M.; Chan, C. C.; Charleson, S.;
Denis, D.; Gauthier, J . Y.; Gordon, R.; Guay, D.; Kargman, S.
Lau, C. K.; Leblanc, Y.; Mancini, J .; Ouellet, M.; Percival, D.;
Roy, P.; Skorey, K.; Tagari, P.; Vickers, P.; Wong, E.; Xu, L.;
Prasit, P. From Indomethacin to a Selective COX-2 Inhibitor-
Development of Indolalkanoic Acids as Potent and Selective
Cyclooxygenase-2 Inhibitors. Bioorg. Med. Chem. Lett. 1996, 6,
725-730.
(9) (a) Trummlitz, G.; Engel, W.; Seeger, E.; Engelhardt, G. 4-Hy-
droxy-2H-1,2-benzothiazine-3-carboxamide-1,1-Dioxides and Salts
Thereof. U.S. Patent 4,233,299, 1980 (b) Engelhardt, G.; Homma,
D.; Schlegel, K.; Ultzmann, R.; Schnitzler, C. Anti-Inflammatory,
Analgesic, Antipyretic and Related Properties of Meloxicam, a
New Nonsteroidal Anti-Inflammatory Agent with Favourable
Gastrointestinal Tolerance. Inflamm. Res. 1995, 44, 423-433.
(c) Engelhardt, G.; Homma, D.; Schnitzler, C. Meloxicam:
Potent Inhibitor of Adjuvant Arthritis in the Lewis Rat. In-
flamm. Res. 1995, 44, 548-545.
A
(10) (a) Patoia, L; Santucci, L.; Furno, P. et al. A 4-Week Double
-Blind, Parallel- Group Study to Compare the Gastrointestinal
Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20
mg and Placebo by Means of Faecal Blood Loss, Endoscopy and
Symptoms Evaluation in Healthy Volunteers. Br. J . Rheumatol.
1996, 35 (Suppl. 1), 61-67. (b) Bird, H. A.; Bevis, P. J . R.;
Lapham, G. An Open Study to Assess the Safety and Tolerability
of Meloxicam 15 mg in Subjects with Rheumatoid Disease and
Mild Renal Impairment. Br. J . Rheumatol. 1996, 35 (Suppl. 1),
56-60. (c) Distel, M.; Mueller, C.; Bluhmki, E.; Fries, J . Safety
of Meloxicam: A Global Analysis of Clinical Trials. Br. J .
Rheumatol. 1996, 35 (Suppl. 1), 68-77.
(28) Holford, N. H. G.; Sheiner, L. B.; Pharmacokinetic and phar-
macodynamic modeling in vivo. Crit. Rev. Bioeng. 1981, 5, 273-
322.
(29) Holford, N. H. G.; Sheiner, L. B. Kinetics of phamacologic
response. Pharmacol Ther. 1982, 16, 143-166.
(11) (a) Churchill, L.; Graham, A. G.; Shih, C-K.; Pauletti, D.; Farina,
P. R.; Grob, P. M. Selective Inhibition of Human Cyclooxyge-
nase-2 by Meloxicam. Inflammopharmacology 1996, 4, 125-135.
J M9607010